Saudi CMA fines 11 former Saudi German Health officials SR18 million for revenue manipulation

Saudi Arabia’s Capital Market Authority has issued a final ruling against 11 former board and audit committee members of Middle East Healthcare Company, the operator of Saudi German Health hospitals, fining them a combined SR18 million over financial statement manipulation linked to revenues recognized between 2018 and 2021.

According to the CMA, the Appeal Committee for the Resolution of Securities Disputes found the officials responsible for violations tied to the company’s recognition of revenues that were unlikely to be collected. Regulators said the practice created a misleading picture of the company’s financial position and inflated both reported revenues and assets in its disclosures. The case covered financial statements from the year ending December 31, 2018, through the interim period ending September 30, 2021.

The ruling also included work bans for some of the convicted individuals, preventing them from working at entities supervised by the CMA for periods ranging from six months to one year. Saudi Gazette reported that the penalties were imposed on former board and audit committee members, reflecting the regulator’s focus on governance failures at senior levels of the company. The CMA said the decision was final.

The case is part of a broader push by Saudi regulators to strengthen market transparency and accountability. In a separate development reported by Saudi Gazette, the CMA also referred 17 suspects linked to Cenomi Retail to the Public Prosecution over alleged market violations, underscoring that the authority is pursuing enforcement actions across the listed-company sector. Together, the cases show growing scrutiny of disclosure practices, board oversight and financial reporting standards in Saudi Arabia’s capital market.

The financial misstatement case involving Saudi German Health matters because it affects investors’ trust in company accounts, which are used to assess value, risk and performance. When revenues are overstated or doubtful receivables are recorded as if they will be paid, shareholders and lenders can be misled about a company’s health. The CMA said the violations led to inaccurate information being included in the company’s financial disclosures, a serious issue in public markets where timely and reliable reporting is essential.

The ruling also follows earlier regulatory and legal steps. The CMA said the matter was referred to the Public Prosecution in March 2024, and the final decision was issued in coordination with relevant authorities in connection with a public criminal case. That sequence suggests the case could have consequences beyond the administrative fines already announced, although the sources provided do not detail any further court outcome.